Natalie Sacks
Director · Caribou Biosciences, Inc.
Individual
- 2026
- Feb 20, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Natalie Sacks files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Timothy P. Kelly - $18K in CRBU purchases and sales in the last 12 months
- Barbara G. McClung - $14K in CRBU purchases and sales in the last 12 months
- Ruhi Ahmad Khan - $14K in CRBU purchases and sales in the last 12 months
- Tina M. Albertson - $2K in CRBU purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Natalie Sacks?
Natalie Sacks is a corporate insider, tracked as Director of Caribou Biosciences, Inc. (CRBU). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Natalie Sacks last file a Form 4?
The only primary Form 4 on record is dated 20 February 2026.